CN109457029B - Mettl3基因的应用及其检测方法 - Google Patents
Mettl3基因的应用及其检测方法 Download PDFInfo
- Publication number
- CN109457029B CN109457029B CN201811644223.6A CN201811644223A CN109457029B CN 109457029 B CN109457029 B CN 109457029B CN 201811644223 A CN201811644223 A CN 201811644223A CN 109457029 B CN109457029 B CN 109457029B
- Authority
- CN
- China
- Prior art keywords
- mettl3
- gene
- rheumatoid arthritis
- preparation
- expression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Rheumatology (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Pain & Pain Management (AREA)
- Pathology (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811644223.6A CN109457029B (zh) | 2018-12-30 | 2018-12-30 | Mettl3基因的应用及其检测方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811644223.6A CN109457029B (zh) | 2018-12-30 | 2018-12-30 | Mettl3基因的应用及其检测方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109457029A CN109457029A (zh) | 2019-03-12 |
CN109457029B true CN109457029B (zh) | 2020-06-23 |
Family
ID=65615822
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811644223.6A Active CN109457029B (zh) | 2018-12-30 | 2018-12-30 | Mettl3基因的应用及其检测方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109457029B (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108929863B (zh) * | 2018-07-05 | 2019-11-22 | 浙江大学 | Mettl3基因敲除的细胞系及其构建方法与干扰载体 |
CN111118143B (zh) * | 2020-01-16 | 2020-09-15 | 西安市红会医院 | 检测及靶向rp11-754b17.1的试剂及其在关节炎中的应用 |
CN111471097B (zh) * | 2020-04-08 | 2021-07-30 | 青岛市中心医院 | 白介素37的应用及对肺癌细胞RNA m6A甲基化影响的试验方法 |
CN112359107B (zh) * | 2020-11-15 | 2021-09-14 | 安徽中医药大学第一附属医院(安徽省中医院) | Linc02085基因的应用及其检测方法 |
CN114796466B (zh) * | 2022-05-05 | 2023-10-24 | 江苏省人民医院(南京医科大学第一附属医院) | 一种星型胶质细胞特异性mettl3过表达的重组腺相关病毒的应用 |
CN115011577B (zh) * | 2022-06-21 | 2023-05-09 | 首都师范大学 | 昆虫m6A甲基化转移酶METTL3基因片段及其dsRNA和应用 |
CN115814088B (zh) * | 2022-09-28 | 2024-05-17 | 南京医科大学 | 甲基转移酶样蛋白4的制药用途 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107349217B (zh) * | 2017-07-21 | 2020-06-09 | 深圳大学 | 一种基于mettl3的小干扰rna及其药物和应用 |
CN108342482B (zh) * | 2018-04-09 | 2021-05-25 | 中山大学 | 一种胶质母细胞瘤标记物及其应用、试剂盒 |
-
2018
- 2018-12-30 CN CN201811644223.6A patent/CN109457029B/zh active Active
Non-Patent Citations (1)
Title |
---|
Homo sapiens methyltransferase like 3 (METTL3), mRNA;GENBANK;《NCBI Reference Sequence: NM_019852.5》;20181123 * |
Also Published As
Publication number | Publication date |
---|---|
CN109457029A (zh) | 2019-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109457029B (zh) | Mettl3基因的应用及其检测方法 | |
Fan et al. | Effect of lncRNA MALAT1 on rats with myocardial infarction through regulating ERK/MAPK signaling pathway. | |
CN109852688B (zh) | 一种2型糖尿病的诊断引物及试剂盒、以及非编码rna分子标志物的应用 | |
US20190153446A1 (en) | Mir-149-3p and method for treating metabolic disease using the same | |
CN112280857B (zh) | 一种用于肝细胞癌诊断的生物标志物及其应用 | |
JP2022521997A (ja) | 全身性エリテマトーデスを治療するための医薬の調製における環状rnaの使用 | |
US10123997B2 (en) | Target for treating hepatitis B virus | |
Fang et al. | MicroRNA-544 inhibits inflammatory response and cell apoptosis after cerebral ischemia reperfusion by targeting IRAK4. | |
CN108660212B (zh) | Wdr1基因在制备非小细胞肺癌治疗和检测产品中的应用 | |
CN107937532B (zh) | 胶质瘤诊断标志物hsa_circ_0021827及应用 | |
CN110129451B (zh) | 一种胃肠道恶性肿瘤标志物及其应用 | |
CN114317720B (zh) | hsa_circ_0066715基因的应用及其检测方法 | |
CN107012207B (zh) | Lrp5作为临床诊断和抑制消化系统肿瘤的应用 | |
CN112680512B (zh) | 一种环状RNA生物标志物circ-Glis3的应用 | |
CN107151695B (zh) | 用于检测急性心肌缺血疾病的piRNA组合及其检测方法和应用 | |
CN111154863B (zh) | lncRNA在制备诊断和/或治疗骨关节炎的产品中的应用 | |
CN114277119B (zh) | 一种环状RNA circ-Arsb在制备防治骨质疏松产品中的应用 | |
Lu et al. | The Effect of lncRNA-PVT1 on Liver Cancer Rats by Regulating the Expression of MMP9 | |
CN111893090B (zh) | 一种动脉粥样硬化防治药物筛选细胞模型及其构建和应用 | |
AU2021100731A4 (en) | A Use of PIWI interacting RNA piR-hsa-211106 | |
CN113789380B (zh) | 一种长链非编码RNA lncRNA JPX作为骨肉瘤分子标志物的应用 | |
CN111235263B (zh) | 诊治骨关节炎的靶基因 | |
CN113398247B (zh) | 促进cd44水平的物质在制备通过促进cd44治疗/预防血管内皮炎症的产品中的应用 | |
WO2020248771A1 (zh) | 基于hsa-miR-320a的糖尿病早期预警和/或诊断试剂盒的制备方法、防治糖尿病的药物及其筛选方法和制备方法 | |
CN107557474B (zh) | 胶质瘤诊断标志物circ15:98707562|98708107及应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Xu Donghua Inventor after: Wang Zengyan Inventor after: Wang Pingping Inventor after: Wang Zengfang Inventor after: Xu Yang Inventor after: Yan Shushan Inventor after: Wang Jinghua Inventor before: Wang Zengyan Inventor before: Wang Pingping Inventor before: Wang Zengfang Inventor before: Xu Yang Inventor before: Yan Shushan Inventor before: Xu Donghua Inventor before: Wang Jinghua |
|
CB03 | Change of inventor or designer information | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20200525 Address after: Weifang City, Shandong province 261000 g street Kuiwei District No. 151 Applicant after: The First Affiliated Hospital of Weifang Medical University Address before: 262299 Jinhuiyuan East District, South Ring Road, Zhucheng City, Weifang City, Shandong Province Applicant before: Wang Zengyan |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant |